Evidence map›Paper›PMID 27548915›Full record

ArticleNature cell biology2016

Melanoma miRNA trafficking controls tumour primary niche formation.

Shani Dror, Laureen Sander, Hila Schwartz, Danna Sheinboim, Aviv Barzilai, Yuval Dishon, Sebastien Apcher, Tamar Golan, Shoshana Greenberger, Iris Barshack and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 1 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 1 synthesis or guideline pooled it, 203 citations in OpenAlex.

  1. The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy.International journal of molecular sciences · 2022
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Melanosomes support immune evasion in melanoma.Cellular & molecular immunology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 4 countries.

Shani DrorDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Laureen SanderFunctional Genome Analysis, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg 69120, Germany.
Hila SchwartzDepartment of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Danna SheinboimDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Aviv BarzilaiInstitute of Pathology, Sheba Medical Center, Tel Hashomer 52621, Israel.
Yuval DishonDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Sebastien ApcherDepartment of Immunology, Institut Gustave Roussy, Université Paris, 94805 Villejuif, France.
Tamar GolanDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Shoshana GreenbergerInstitute of Pathology, Sheba Medical Center, Tel Hashomer 52621, Israel.
Iris BarshackInstitute of Pathology, Sheba Medical Center, Tel Hashomer 52621, Israel.
Hagar MalcovDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Alona ZilberbergDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Lotan LevinDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Michelle NesslingImaging and Cytometry Core Facility, Unit for Electron Microscopy, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg 69120, Germany.
Yael FriedmannThe Bio-Imaging Unit, Hebrew University, Jerusalem 91904, Israel.
Vivien IgrasCutaneous Biology Research Center, Department of Dermatology and MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Ohad BarzilayColler School of Management, Tel Aviv University, Tel Aviv 69978, Israel.
Hananya VaknineInstitute of Pathology, E. Wolfson Medical Center, Holon 58100, Israel.
Ronen BrennerInstitute of Pathology, E. Wolfson Medical Center, Holon 58100, Israel.
Assaf ZingerDepartment of Chemical Engineering, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Avi SchroederDepartment of Chemical Engineering, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Pinchas GonenDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Mehdi KhaledINSERM 1186, Gustave Roussy, Université Paris-Saclay, Villejuif 94805, France.
Neta ErezDepartment of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Jörg D HoheiselFunctional Genome Analysis, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg 69120, Germany.
Carmit LevyDepartment of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Tel Aviv University · ILSheba Medical Center · ILGerman Cancer Research Center · DETechnion – Israel Institute of Technology · ILWolfson Medical Center · ILHebrew University of Jerusalem · ILHeidelberg University · DEInserm · FRInstitut Gustave Roussy · FRMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma originates in the epidermis and becomes metastatic after invasion into the dermis. Prior interactions between melanoma cells and dermis are poorly studied. Here, we show that melanoma cells directly affect the formation of the dermal tumour niche by microRNA trafficking before invasion. Melanocytes, cells of melanoma origin, are specialized in releasing pigment vesicles, termed melanosomes. In melanoma in situ, we found melanosome markers in distal fibroblasts before melanoma invasion. The melanosomes carry microRNAs into primary fibroblasts triggering changes, including increased proliferation, migration and pro-inflammatory gene expression, all known features of cancer-associated fibroblasts (CAFs). Specifically, melanosomal microRNA-211 directly targets IGF2R and leads to MAPK signalling activation, which reciprocally encourages melanoma growth. Melanosome release inhibitor prevented CAF formation. Since the first interaction of melanoma cells with blood vessels occurs in the dermis, our data suggest an opportunity to block melanoma invasion by preventing the formation of the dermal tumour niche.

Indexed as

AnimalsBiological TransportCell MovementEpidermisFibroblastsHumansMelanocytesMelanomaMelanosomesMiceMicroRNAsSkin NeoplasmsTumor Cells, CulturedMicroRNAsMIRN211 microRNA, humanMirn211 microRNA, mouse

Identifiers

PMID27548915
OpenAlexW2510540705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.